Management of candidemia in patients with Clostridium difficile infection.

Abstract

INTRODUCTION Patients with C. difficile infection (CDI) experience intestinal microflora changes that can promote the overgrowth and subsequent translocation of gut resident pathogens into the blood. Consistently, CDI due to PCR-ribotype 027 strain, severe or relapsing CDI, and treatment with high-dosage vancomycin are independent risk factors for… (More)
DOI: 10.1080/14787210.2016.1197118

Topics

1 Figure or Table

Cite this paper

@article{Falcone2016ManagementOC, title={Management of candidemia in patients with Clostridium difficile infection.}, author={Marco Aurelio Falcone and Mario Venditti and Maurizio Sanguinetti and Brunella Posteraro}, journal={Expert review of anti-infective therapy}, year={2016}, volume={14 7}, pages={679-85} }